FRMM vs QNRX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
QNRX Captures Institutional Edge (2โ1 Pillars ยท 8โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quoin Pharmaceuticals, Ltd. American Depositary Shares (QNRX) driven by superior Valuation, Growth & Margin while FRMM counters with relative strength in Momentum & Technical. Fundamentally, FRMM trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus QNRX at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, FRMM sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against QNRX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | FRMM | QNRX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $16.1M | Larger Scale | QNRX |
| Trailing P/E Ratio Valuation | N/M | 7.6x | Lower Multiple | QNRX |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | N/A | +0.0% | Higher Growth | QNRX |
| Operating Margin (TTM) Profitability | N/A | 0.0% | Higher Margin | QNRX |
| Net Profit Margin Profitability | N/A | 0.0% | Higher Margin | QNRX |
| Return on Equity (ROE) Capital Efficiency | N/A | -142.6% | Higher ROE | QNRX |
| 52-Week Range Position Momentum | 3% ($2โ$7) | 0% ($3โ$24) | Stronger Trend | FRMM |
| Beta / 30D Volatility Risk Regime | 2.28ฮฒ ยท 107% Vol | 1.34ฮฒ ยท 74% Vol | Lower Realized Risk | QNRX |
| Unified Institutional Score Composite Signal | 42.5 / 100 (HOLD) | 46.1 / 100 (HOLD) | Higher Composite | QNRX |